Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GZR101 vs GZR33-70 in Type 2 Diabetes
NCT06558708Phase 2Recruiting
- Sponsor
- Gan & Lee Pharmaceuticals
- Start
- Jun 2024
- Primary completion
- Dec 2024
- Modality
- Insulin and Analogs
- Countries
- 1
01
Overview
A Phase 2 trial of GZR101 in type 2 diabetes mellitus (T2DM), sponsored by Gan & Lee Pharmaceuticals. Started Jun 2024; status: recruiting.
02
Drugs
GZR101
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06558708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06558708.